MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/Pi3k/Akt Pathway and Tumor Growth in Prostate Cancer
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-9-142
Full Text
Open PDFAbstract
Available in full text
Date
May 11, 2009
Authors
Publisher
Springer Science and Business Media LLC